Targeted pharmacotherapy after somatic cancer mutation screening

Many patients with solid tumours are treated with targeted pharmacotherapy based on the results of genetic testing (‘precision medicine’). This study investigated the use of targeted drugs after OncoFOCUS™+ KIT screening in patients with malignant melanoma, non-small cell lung cancer and metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Polasek, Thomas M., Ambler, Karen, Scott, Hamish S., Sorich, Michael J., Kaub, Peter A., Rowland, Andrew, Wiese, Michael D., Kichenadasse, Ganessan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247780/
https://www.ncbi.nlm.nih.gov/pubmed/28163892
http://dx.doi.org/10.12688/f1000research.9040.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247780/
https://www.ncbi.nlm.nih.gov/pubmed/28163892
http://dx.doi.org/10.12688/f1000research.9040.2

Ejemplares similares